Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
C-DOOR is a South Korean medical technology company specializing in artificial intelligence-driven diagnostic support systems for endoscopy. The company's primary focus is the development of real-time AI solutions that assist clinicians in detecting and characterizing lesions during gastroscopy and colonoscopy procedures. By leveraging deep learning algorithms, C-DOOR's technology aims to reduce the miss rate of gastrointestinal cancers and improve the accuracy of endoscopic examinations. Their flagship products are designed to integrate seamlessly with existing endoscopy equipment to provide immediate clinical decision support. The company's technology has been validated through clinical trials in major South Korean medical institutions and has received regulatory clearance from the Ministry of Food and Drug Safety (MFDS).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CDoor.